HRT Financial’s Lydall, Inc. LDL Stock Holding History

HRT Financial’s Portfolio LDL Stock Details LDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,040	Closed	-$486K	–	3987
2021 Q2	$486K	Buy	+8,040	New	+$309K	﹤0.01%	1811
2020 Q4	–	Sell	-13,545	Closed	-$224K	–	2748
2020 Q3	$224K	Buy	+13,545	New	+$236K	0.01%	1306

Other funds holding LDL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HRT Financial's LDL Position: Q3 2021 in Review

HRT Financial sold out of Lydall, Inc. (LDL) in Q3 2021, closing a stake of 8,040 shares — an estimated $486K sold.

HRT Financial first reported a position in LDL in Q3 2020 and held it in 2 quarters. The position peaked at $486K in Q2 2021. 158 funds tracked by Wall St. Rank hold LDL as of Q3 2021.

HRT Financial reported no remaining Lydall, Inc. position as of Q3 2021 after selling out during the quarter.
HRT Financial sold 8,040 Lydall, Inc. shares in Q3 2021, an estimated $486K.
HRT Financial first reported a position in Lydall, Inc. in Q3 2020 and held it in 2 quarters.
HRT Financial's Lydall, Inc. position peaked at $486K in Q2 2021.
158 funds tracked by Wall St. Rank held Lydall, Inc. as of Q3 2021.

Based on HRT Financial's 13F filing for Q3 2021, filed 15 Nov 2021.